Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial.
暂无分享,去创建一个
David Gur | Andriy I Bandos | Per Skaane | Randi Gullien | Sofie Sebuødegård | Solveig Hofvind | D. Gur | P. Skaane | L. Niklason | S. Hofvind | S. Sebuødegård | R. Gullien | Loren T Niklason | Bjørn H Østerås | B. H. Østerås | A. Bandos | Randi Gullien
[1] M. Papotti,et al. Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up , 2016, Breast Cancer Research and Treatment.
[2] A. Beck,et al. Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses’ Health Study , 2017, Breast Cancer Research and Treatment.
[3] A. Rosso,et al. False positives in breast cancer screening with one-view breast tomosynthesis: An analysis of findings leading to recall, work-up and biopsy rates in the Malmö Breast Tomosynthesis Screening Trial , 2016, European Radiology.
[4] Andriy I. Bandos,et al. Prospective trial comparing full-field digital mammography (FFDM) versus combined FFDM and tomosynthesis in a population-based screening programme using independent double reading with arbitration , 2013, European Radiology.
[5] Andriy I Bandos,et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. , 2014, Radiology.
[6] Anders Tingberg,et al. Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö Breast Tomosynthesis Screening Trial, a population-based study , 2015, European Radiology.
[7] David Gur,et al. Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial , 2018, Breast Cancer Research and Treatment.
[8] N. Houssami,et al. Digital Breast Tomosynthesis with Synthesized Two-Dimensional Images versus Full-Field Digital Mammography for Population Screening: Outcomes from the Verona Screening Program. , 2017, Radiology.
[9] Eugenio Paci,et al. Breast Cancer Mortality in Mammographic Screening in Europe: A Review of Incidence-Based Mortality Studies , 2012, Journal of medical screening.
[10] Carrie M. Rochman,et al. Outcome of Architectural Distortion Detected Only at Breast Tomosynthesis versus 2D Mammography. , 2018, Radiology.
[11] Andrew Oustimov,et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. , 2016, JAMA oncology.
[12] Pragya A. Dang,et al. Breast Cancer Characteristics Associated with 2D Digital Mammography versus Digital Breast Tomosynthesis for Screening-detected and Interval Cancers. , 2017, Radiology.
[13] Per Skaane,et al. Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Digital Mammography: Evaluation in a Population-based Screening Program. , 2018, Radiology.
[14] L. Tabár,et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. , 2011, Radiology.
[15] C. Field,et al. Bootstrapping clustered data , 2007 .
[16] C. Lehman,et al. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. , 2015, JAMA internal medicine.
[17] Anne Marie McCarthy,et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium , 2016, Breast Cancer Research and Treatment.
[18] Emily F Conant,et al. Breast cancer screening using tomosynthesis in combination with digital mammography. , 2014, JAMA.
[19] Andriy I. Bandos,et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. , 2013, Radiology.